retatrutide phase 2 trial results clinical data Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with retatrutide dosing phase 2 trial
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31































